MTSR Metsera, Inc. Common Stock

$52.90

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 10/7/2025

About Metsera, Inc. Common Stock

Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. The company is headquartered in New York, New York.

Website: https://metsera.com

Sector
TECHNOLOGY
Industry
GENERAL
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
nan
Address
NONE
Valuation
Market Cap
$3.09B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
0.00
Performance
EPS
$nan
Dividend Yield
Profit Margin
0.00%
ROE
0.00%
Technicals
50D MA
$28.43
200D MA
$28.43
52W High
$32.81
52W Low
$12.30
Fundamentals
Shares Outstanding
15M
Target Price
$nan
Beta
nan

MTSR EPS Estimates vs Actual

Estimated
Actual

MTSR News & Sentiment

Oct 07, 2025 • Benzinga SOMEWHAT-BULLISH
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. ( Nasdaq - PINC ) , Metsera, Inc. ( Nasdaq - MTSR ) , Anywhere Real Estate Inc. ( NYSE - HOUS ) , The ODP Corporation ( Nasdaq - ODP )
BALA CYNWYD, Pa., Oct. 07, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.
Oct 07, 2025 • Motley Fool SOMEWHAT-BULLISH
Down 50%, Should You Buy the Dip on Pfizer?
Pfizer's stock price is down materially from its 2021 highs, but it is also up notably from its April 2025 lows.
Oct 06, 2025 • Motley Fool SOMEWHAT-BULLISH
3 Reasons to Buy Pfizer Stock Now
After years of underperformance, the future is looking brighter for the drugmaker.
Oct 03, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is PFE Stock a Buy After 14% Rise Post Drug Pricing Deal With Trump?
Pfizer surges 14% after landmark Trump deal slashing drug prices while boosting U.S. investments.
Oct 03, 2025 • Motley Fool SOMEWHAT-BULLISH
2 Reliable Dividend Stocks With Yields Above 6% That You Can Buy With $100 in October
You don't need to be rich to put your money to work on Wall Street.
Oct 02, 2025 • Motley Fool NEUTRAL
3 Things You Need to Know if You Buy Pfizer Today
Pfizer has an attractive 7.2% dividend yield, but there are some pros and cons you need to understand before you buy it.
Sentiment Snapshot

Average Sentiment Score:

0.191
50 articles with scored sentiment

Overall Sentiment:

Bullish

MTSR Reported Earnings

Jul 28, 2025
Jun 30, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $-0.66
  • Estimate: $0.00
  • Whisper:
  • Surprise %: 0.0%
May 12, 2025
Mar 31, 2025 (Pre market)
0.01 Surprise
  • Reported EPS: $-1.03
  • Estimate: $-1.04
  • Whisper:
  • Surprise %: 1.0%
Feb 26, 2025
Dec 31, 2024 (Pre market)
-2.72 Surprise
  • Reported EPS: $-3.52
  • Estimate: $-0.80
  • Whisper:
  • Surprise %: -340.0%

Financials